Literature DB >> 20433555

Serum insulin is significantly related to components of the metabolic syndrome in Japanese working men.

Tomoyuki Kawada1, Hirofumi Inagaki, Yoko Wakayama, Qing Li, Masao Katsumata.   

Abstract

The aim of this study was to examine the association between serum insulin levels and components of the metabolic syndrome (MS). The target participants were 3054 working men. MS was diagnosed based on the modified criteria of the International Diabetes Federation and was present in 12.9% of the study patients. Serum lipid profiles, uric acid, insulin, plasma glucose, and hemoglobin A1c were measured. Stepwise multiple regression analysis showed that all the components of MS were significantly associated with log-transformed values of the serum insulin. The standardized regression coefficient for the waist circumference was 5-fold higher than that for fasting plasma glucose, being 0.40 and 0.08, respectively. The standardized regression coefficients for diastolic blood pressure, log-transformed values of serum triglyceride, high-density lipoprotein cholesterol, and age were 0.09, 0.13, -0.16, and -0.11, respectively. A statistically significant relationship existed between the components of MS, especially abdominal obesity, and the serum insulin levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20433555      PMCID: PMC8673346          DOI: 10.1111/j.1751-7176.2009.00239.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  23 in total

1.  Predictors for development of hyperuricemia: an 8-year longitudinal study in middle-aged Japanese men.

Authors:  N Nakanishi; H Yoshida; K Nakamura; K Suzuki; K Tatara
Journal:  Metabolism       Date:  2001-06       Impact factor: 8.694

2.  Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers.

Authors:  I Nishizono; S Iida; N Suzuki; H Kawada; H Murakami; Y Ashihara; M Okada
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

3.  The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians.

Authors:  D Pei; S-W Kuo; D-A Wu; T-Y Lin; M-C Hseih; C-H Lee; W-L Hsu; S-P Chen; W H-H Sheu; J-C Li
Journal:  Int J Clin Pract       Date:  2005-12       Impact factor: 2.503

Review 4.  Definition of the metabolic syndrome: current proposals and controversies.

Authors:  Efrain Reisin; Martin A Alpert
Journal:  Am J Med Sci       Date:  2005-12       Impact factor: 2.378

5.  Relationship between obesity, insulin resistance, and coronary heart disease risk.

Authors:  Fahim Abbasi; Byron William Brown; Cindy Lamendola; Tracey McLaughlin; Gerald M Reaven
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

6.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

7.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.

Authors:  David E Laaksonen; Hanna-Maaria Lakka; Leo K Niskanen; George A Kaplan; Jukka T Salonen; Timo A Lakka
Journal:  Am J Epidemiol       Date:  2002-12-01       Impact factor: 4.897

Review 8.  The metabolic syndrome: an emerging risk state for cardiovascular disease.

Authors:  Dorairaj Prabhakaran; Sonia S Anand
Journal:  Vasc Med       Date:  2004-02       Impact factor: 3.239

9.  Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults.

Authors:  J B McPhillips; E Barrett-Connor; D L Wingard
Journal:  Am J Epidemiol       Date:  1990-03       Impact factor: 4.897

Review 10.  Insulin resistance, hypertension, and coronary heart disease.

Authors:  Gerald Reaven
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.